PRESS RELEASE

Annual Report and Notice of AGM

London, UK - 21 May 2018:Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a company focused on providing specialised services to the pharmaceutical industry, announces that it will host its Annual General Meeting at the offices of Covington & Burling LLP, 265 Strand, London WC2R 1BH at 9.30am on Tuesday 12th June 2018.

The Annual Report and Accounts for the year ended 31 December 2017, Notice of AGM and Proxy have been mailed to shareholders today, Monday 21st May 2018. The Annual Report and Accounts will be available on the Company's website:www.ergomedplc.com.

- ENDS -

Enquiries:

Ergomed plc

Tel: +44 (0) 1483 503 205

Stephen Stamp (Chief Executive Officer)

Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black (Joint Broker)

N+1 Singer(Joint Broker)

Tel: +44 (0) 20 7496 3000

Alex Price

Consilium Strategic Communications- for UK enquiries

Tel: +44 (0) 20 3709 5700

Chris Gardner / Mary-Jane Elliott

Ivar Milligan / Philippa Gardner

ergomed@consilium-comms.com

MC Services - for Continental European enquiries

Tel: +49 211 5292 5222

Anne Hennecke

About Ergomed

Ergomed provides specialist services to the pharmaceutical industry and develops drugs both wholly-owned and through partnerships. Ergomed's fast-growing, profitable service offering spans all phases of clinical development and post-approval pharmacovigilance and medical information. Drawing on more than 20 years of expertise in drug development, Ergomed has established aportfolio of drug development partnerships and programmes, including wholly-owned proprietary products for the treatment of surgical bleeding. For further information, visit:http://ergomedplc.com.

Attachments

  • Original document
  • Permalink

Disclaimer

Ergomed plc published this content on 21 May 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 21 May 2018 14:44:07 UTC